Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
1611 Initial Results of Bladder Preserving Approach by Chemo-Radiotherapy in Patients with Muscle Invading Transitional Cell Carcinoma
 		Department of Surgical Oncology Ahmed Mokhtar Abdel- Rahim Abdel-Moneem 2009
1612 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Radiotherapy and Nuclear medicine Prof. Mostafa El-Sayed Abdalones Mohamed 2009
1613 Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids. Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2009
1614 Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis. Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2008
1615 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2008
1616 Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis. Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008
1617 Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?
 		Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008
1618 Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder which protein is prognostic Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008
1619 Pharmacokinetics of oral tramadol in patients with liver cancer.
 		Department of Anesthesia, Intensive care and Pain management Prof. Mustafa Galal Mustafa Hassan 2008
1620 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008